The company "Ananta Medicare" supported the holding of the rheumatology school and took part in it. More than 1,500 doctors have got acquainted with the materials of the school remotely.

Scientists from the United States have found that a certain class of antibiotics could be promising for the treatment of frontotemporal dementia.

By using a new approach, scientists have developed an experimental vaccine against Toxoplasma gondii.

A study has shown that sequential administration of two different Ebola virus vaccines at regular intervals may provide the best immune response.

European Medicines Agency is considering the application of the American Bluebird Bio for the registration of cerebral adrenoleukodystrophy drug.

Department of the National Health Service of UK in association with the NHS Business Services Authority have developed RTEC based drug dispensing platform.

The FDA has approved the anticoagulant Brilinta for use in patients with cardiovascular disease.

In a small study, a biotech company has tested its own amyotrophic lateral sclerosis drug.

On 22nd of September 2020 the company "Ananta Medicare" in association with "Clinic of modern rheumatology" held the first webinar on the topic of osteoporosis. The lecture "Osteoporosis - from idea to action" was conducted by prof. Egudina Elizaveta Davydovna.

Scenic Biotech founders and biologists have designed their own functional genomics platform to accurately identify genes that modify a specific disease.